AB1455 FLUORIDE UPTAKE ON QUANTITATIVE POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY (NA18F-PET/CT) AS NOVEL BIOMARKER FOR DISEASE ACTIVITY IN ADULT CHRONIC NONBACTERIAL OSTEOMYELITIS/SYNOVITIS ACNE PUSTULOSIS HYPEROSTOSIS OSTEITIS SYNDROME (CNO/SAPHO)

نویسندگان

چکیده

Background Chronic nonbacterial osteomyelitis (CNO) is a rare bone disease characterized by sterile inflammation and locally increased turnover. CNO that occurs in the rheumatic spectrum of synovitis, acne, pustulosis, hyperostosis osteitis referred to as SAPHO syndrome [1, 2]. To date, there are no objective biomarkers for monitoring activity. Recommended imaging tools like technetium radiolabeled hydroxymethylene diphosphonate single positron emission computed tomography visualize turnover, but fail reflect relapsing-remitting activity course due an imprinting pattern [3]. Likewise, magnetic resonance can track fluctuation marrow edema, inferior compared (CT) capturing subtle inflammatory accumulated structural changes duration. Sodium fluoride-18 tomography/CT(Na 18 F-PET/CT) another modality which produces quantitative data on spatial distribution turnover also correlate with clinical other metabolic diseases [4]. Objectives We quantified F-uptake CNO/SAPHO patients evaluate its capacities biomarker. Methods Cohort study including 43 not using immunomodulatory or antiresorptive medications Na F-PET/CT performed at our expert clinic between 2019-2022. Images were qualitatively assessed following systematic reporting format. Maximal standardized uptake values (SUV max ) determined areas defined radiologic appearance CT: osteitic (osseous lesions), inflamed ligaments joint spaces (soft tissue lesions) thoracic vertebrae 5 reference (ref-bone). Results Qualitative assessment revealed sclerosis manubrium most prevalent features (present 77% 70%) costae 1-2 (79% each). Calcification/ankylosis costoclavicular ligament was seen 58%. Quantitative analyses showed higher SUV osseous soft lesions ref-bone (mean 22±6 26±9 vs. 11±3 g/mL, p<0.001 paired difference). Stratified per location, highest found followed manubriosternal 29±13 25±8 respectively). positively correlated erythrocyte sedimentation rate (Spearman correlation coefficient 0.546, p<0.01 ). Conclusion display distinctive qualitative well-captured F-PET/CT, show ref-bone. Diseased . Considering F precipitates young osteoid, these high may process ossification common long-existing CNO/SAPHO, demonstrated fibrodysplasia ossificans progressiva [5]. Further studies should promising application novel biomarker therapy response CNO/SAPHO. References [1]Leerling et al. Clinical therapeutic diversity adult chronic sternocostoclavicular region: meta-analysis. Rheumatology 2022. [2]Rukavina I. syndrome: review. J Child Orthop 2015. [3]Li A retrospective scintigraphy follow-up it useful repeat assessment? 2019. [4]van der Bruggen Quantifying skeletal burden fibrous dysplasia sodium fluoride PET/CT. Eur Nucl Med Mol Imaging 2020. [5]Botman Evolution heterotopic progressiva: An [(18)F]NaF PET/CT study. Bone Acknowledgements: NIL. Disclosure Interests None Declared.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

SAPHO Syndrome: Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis

A 68-year-old woman with a history of breast cancer, who had undergone left quadrantectomy 24 years prior, had suffered from palmoplantar pustulosis (PPP) and pain in multiple joints and bones for 3 years. Technetium bone scanning showed increased uptake in the sternum, sternocostoclavicular joint, cervical vertebrae, lumbar vertebrae, and right knee (Picture 1, left). A radiograph of the lumba...

متن کامل

Infliximab for Treatment of Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome: A Case Report

Vol. 29, No. 1, 2017 131 Received December 18, 2015, Revised February 5, 2016, Accepted for publication March 10, 2016 Corresponding author: Takaaki Hanafusa, Department of Dermatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Yushima 1-5-45, Bunkyo-ku, Tokyo 113-8519, Japan. Tel: 81-3-5803-5282, Fax: 81-3-5803-5289, E-mail: [email protected] This is...

متن کامل

Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Syndrome in Childhood; A Rare Clinical Entity

Ayşe Sayılı*1, MD, Ozgur Tosun2, Nazan Cobanoglu1, Nerin Bahceciler Onder1, Fusun Baba3, Salih Kavukcu1 1Department of Pediatrics, 2Department of Radiology, 3Department of Pathology, Near East University Faculty of Medicine, Turkish Republic of Northern Cyprus Received: Sep 11, 2013; Accepted: Apr 23, 2014; First Online Available: Aug 15, 2014 Dear Editor, Referring to synovitis, acne, pustulos...

متن کامل

Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome.

OBJECTIVE The aetiology of SAPHO (synovitis, acne, palmoplantar pustulosis, hyperostosis, osteitis) syndrome seems to involve genetic, infectious and immunological components. We examined innate and adaptive immune responses in SAPHO syndrome, as compared with PsA and RA. We also studied the effect of etanercept on immunological parameters. METHODS We studied 29 patients with SAPHO syndrome, ...

متن کامل

A Case of Successful Treatment of Refractory Synovitis Acne Pustulosis Hyperostosis Osteitis (SAPHO) Syndrome with Adalimumab

Synovitis acne pustulosis hyperostosis osteitis (SAPHO) syndrome is a rare disease that involves the skin, bones and joints. It is thought to be caused by infection with low-toxicity bacteria and to be the result of reactive infectious osteitis. However, this hypothesis has not yet been clearly established. New SAPHO syndrome treatment methods are needed because the disease does not respond to ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Annals of the Rheumatic Diseases

سال: 2023

ISSN: ['1468-2060', '0003-4967']

DOI: https://doi.org/10.1136/annrheumdis-2023-eular.987